fb tracking

Bayer HealthCare LLC v. Drake

Bayer HealthCare produced multivitamin products that it branded as “natural” but that contained synthetic ingredients. Two consumers who were misled by Bayer’s misrepresentation filed a lawsuit in federal district court, claiming that Bayer had violated New York and California consumer protection statutes. Alleging that Bayer’s misrepresentation enabled it to charge consumers an inflated premium price for its products, the plaintiffs asked the court to certify classes of New York and California consumers who had purchased the products at issue. The district court granted class certification, reasoning among other things that common issues predominated over issues affecting only individual consumers. The Ninth Circuit affirmed, and Bayer petitioned for review in the Supreme Court, posing the question whether a federal court may certify a class that contains members with no evidence of injury.

Serving as co-counsel in the Supreme Court, Public Citizen prepared the plaintiffs’ brief in opposition to the petition. The opposition brief explains that the case offers no opportunity to resolve Bayer’s question presented because the plaintiffs had presented evidence that Bayer had charged a price premium, thereby injuring every consumer who had purchased its products. The brief also explains that the courts of appeals agree that class members need not produce evidence of injury prior to class certification. Rather, the question at the class-certification stage is whether common issues predominate over individual issues, not how those issues will be resolved on the merits. And the district court here correctly held that individual issues of injury would not predominate because whether Bayer had charged a price premium—and, if so, the amount of the premium—can be resolved with respect to all class members in a single stroke based on common evidence.